Company Filing History:
Years Active: 2000
Title: Joan Garbabino: Innovator in Lytic Peptide Technology
Introduction
Joan Garbabino is a notable inventor based in Berkeley, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of plants that produce lytic peptides. Her innovative work has the potential to impact various applications in medicine and agriculture.
Latest Patents
Joan holds a patent for "Plants producing lytic peptides - Stabilized ubiquitin-lytic peptide fusion polypeptides and a method of making the same." This patent involves sub-cloning nucleic acid sequences coding for lytic peptides into a plasmid vector that includes a promoter and ubiquitin polypeptide coding sequence. The ubiquitin polypeptide sequence is linked to the 5' end of the lytic peptide nucleic acid sequence and is translated as a fusion polypeptide. This innovative approach enhances the production of lytic peptides in plants.
Career Highlights
Joan is currently associated with Demegen, Inc., where she continues to advance her research and development efforts. Her work at the company focuses on harnessing the potential of lytic peptides for various applications, showcasing her commitment to innovation in biotechnology.
Collaborations
Throughout her career, Joan has collaborated with esteemed colleagues such as Jesse M. Jaynes and William R. Belknap. These collaborations have further enriched her research and contributed to the advancement of her projects.
Conclusion
Joan Garbabino is a pioneering inventor whose work in lytic peptide technology exemplifies the intersection of innovation and biotechnology. Her contributions are paving the way for future advancements in the field.